BridgeMD
New treatment option for Out of Hospital Cardiac Arrest Without ST-segment Elevation
Official title Performance of Coronary CT Angiography to Rule Out Coronary Artery Disease After Out-of-hospital Cardiac Arrest
ClinicalTrials.gov ID: NCT05961488
What this study is testing
- What it's testing
- Out-of-hospital cardiac arrest (OHCA) has multiple etiologies. In the absence of ST-elevation myocardial infarction, percutaneous coronary intervention (PCI) is delayed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients hospitalized in intensive care unit after a resuscitated out-of-hospital cardiac arrest
- No obvious cause for sudden death on anamnestic information, CT brain and CT pulmonary angiogram.
- Absence of ST elevation myocardial infarction Non-
- In-hospital cardiac arrest
- Refractory cardiac arrest
You likely can't join if
- During the Coronary computerized tomographic angiogram :
- Haemodynamic instability requiring high dose of vasopressors (\>1µg/kg/min of Norepinephrine)
- Non sinusal cardiac rhythm
- KDIGO 1 Acute kidney injury
See the full eligibility criteria
- Patients hospitalized in intensive care unit after a resuscitated out-of-hospital cardiac arrest
- No obvious cause for sudden death on anamnestic information, CT brain and CT pulmonary angiogram.
- Absence of ST elevation myocardial infarction Non-
- In-hospital cardiac arrest
- Refractory cardiac arrest
- Indication of immediate coronary angiography
- ST-elevation myocardial infarction or unknown left bundle branch block
- Dynamic or presumably new contiguous ST/T-segment changes
- Cardiogenic shock
- Life-threatening arrhythmias
- Coronary artery bypass graft
- Pregnancy
- Multiple organ failure syndrome
- Know severe chronic kidney disease (GFR \<30mL/min/1,73m²)
- During the Coronary computerized tomographic angiogram :
- Haemodynamic instability requiring high dose of vasopressors (\>1µg/kg/min of Norepinephrine)
- Non sinusal cardiac rhythm
- KDIGO 1 Acute kidney injury
The study team makes the final eligibility decision.
Where it's taking place
- Reims, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.